Loading clinical trials...
Loading clinical trials...
Phase II Trial of Fludarabine Combined With Intravenous Treosulfan and Allogeneic Hematopoietic Stem-cell Transplantation in Patients With Lymphatic Malignancies
Conditions
Interventions
treosulfan
Locations
1
Israel
Chaim Sheba Medical Center
Tel Litwinsky, Tel-Hashomer, Israel
Start Date
March 1, 2010
Primary Completion Date
April 1, 2018
Completion Date
April 1, 2018
Last Updated
April 20, 2016
NCT05529069
NCT06189391
NCT05006716
NCT06026319
NCT05442515
NCT06745076
Lead Sponsor
Sheba Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions